Adele Guglielmi Selected Research

DHES0815A

11/2021

DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adele Guglielmi Research Topics

Disease

2	Neoplasms (Cancer) 01/2022 - 11/2021
1	Turcot syndrome 01/2022
1	Microsatellite Instability 01/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Carcinoma (Carcinomatosis) 11/2021
1	Treatment-Resistant Depressive Disorder 12/2020
1	Hemorrhage 01/2016
1	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 01/2016
1	Edema (Dropsy) 01/2016
1	Hydrocephalus (Hydrocephaly) 01/2016

Drug/Important Bio-Agent (IBA)

1	Biomarkers (Surrogate Marker)IBA 01/2022
1	pembrolizumabIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Alkylating AgentsIBA 11/2021
1	EpitopesIBA 11/2021
1	DHES0815AIBA 11/2021
1	pertuzumabIBA 11/2021
1	A-Form DNA (A-DNA)IBA 11/2021
1	Trastuzumab (Herceptin)FDA Link 11/2021
1	Immunoconjugates (Immunoconjugate)IBA 11/2021
1	pantothenate kinaseIBA 01/2016
1	EnzymesIBA 01/2016
1	Coenzyme A (CoA)IBA 01/2016
1	MorpholinosIBA 01/2016

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 11/2021
1	Therapeutics 12/2020